September 6, 2016

FDA Warning Wire: Bausch & Lomb, Jazz Pharma, Pan Drugs

This week’s U.S. Food and Drug Administration smackdowns targeted dicey sanitary practices at Valeant Pharmaceuticals unit Bausch & Lomb, bogus marketing by a Jazz Pharmaceuticals subsidiary and a fresh batch of suspicious actions by India-based Pan Drugs. Here’s a look at the enforcement.